Indivior Pharmaceuticals, Inc. (INDV): 8 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Mar 13, 2026 | Ryan Barbara Director | 8 | $31.09 | $249 | no history |
| Mar 11, 2026 | Ryan Barbara Director | 31 | $32.56 | $1.0K | no history |
| Mar 11, 2026 | Kingsley Stuart A Director | 940 | $31.87 | $30.0K | no history |
| Jan 7, 2026 | Wheadon David E. Director | 1,771 | $35.39 | $62.7K | no history |
| Jan 7, 2026 | Stejbach Mark Director | 775 | $35.39 | $27.4K | no history |
| Jan 7, 2026 | Ninivaggi Daniel A Director | 775 | $35.39 | $27.4K | no history |
| Jan 7, 2026 | Humphreys Keith Director | 775 | $35.39 | $27.4K | no history |
| Jan 7, 2026 | Ryan Barbara Director | 775 | $35.39 | $27.4K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.